Product Information
LACOSAMIDE 10 MG/ML SOLUTION is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0829 per ML under NDC 70954048810. Its NADAC has been published 199 times since Dec 14, 2022.
FDA first approved this application on Aug 26, 2022. Its Orange Book therapeutic-equivalence code is AA.
The Low Outlier badge above means this manufacturer's average price in the Lacosamide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954048810
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216151FDA Approved
8/26/2022
TE Code
AA
On Market Since
8/26/2022
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 10 MG/ML SOLUTION has been published 199 times since Dec 14, 2022, and over the history we have for it it has declined 38.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0829 per ML |
|---|---|
| All-time high | $0.1693 (Jan 11, 2023) |
| All-time low | $0.0820 (Aug 19, 2026) |
| 52-week high | $0.1070 |
| 52-week low | $0.0820 |
| Median price | $0.1195 |
| Average price | $0.1168 |
| Largest weekly change | +32.8% (Jun 19, 2024) |
| Weeks tracked | 199 |
| Tracking since | Dec 14, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 10 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 10 MG/ML SOLUTION, manufactured by ANI Pharmaceuticals, Inc., is $0.0829 per ML (NDC 70954048810), effective Sep 30, 2026.
How has the price of LACOSAMIDE 10 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 10 MG/ML SOLUTION has declined 38.9%. It has been tracked across 199 weekly CMS publications since Dec 14, 2022.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 10 MG/ML SOLUTION?
Since Dec 14, 2022, the NADAC for LACOSAMIDE 10 MG/ML SOLUTION has ranged from a low of $0.0820 (Aug 19, 2026) to a high of $0.1693 (Jan 11, 2023), with a median of $0.1195 per ML.
Are there cheaper alternatives to LACOSAMIDE 10 MG/ML SOLUTION?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LACOSAMIDE 10 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures LACOSAMIDE 10 MG/ML SOLUTION?
LACOSAMIDE 10 MG/ML SOLUTION (NDC 70954048810) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.